VANGUARD GROUP INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$541,694,188
-19.4%
3,203,585
+3.4%
0.01%
-18.8%
Q2 2023$671,779,399
+22.5%
3,097,899
+2.6%
0.02%
+14.3%
Q1 2023$548,470,335
+1.4%
3,019,546
+9.7%
0.01%
-6.7%
Q4 2022$541,071,199
-8.2%
2,753,543
+5.0%
0.02%
-11.8%
Q3 2022$589,672,000
+114.5%
2,621,585
+20.7%
0.02%
+112.5%
Q2 2022$274,870,000
+2.2%
2,172,714
+2.4%
0.01%
+33.3%
Q1 2022$268,940,000
-1.5%
2,121,152
+1.8%
0.01%0.0%
Q4 2021$273,048,000
+8.1%
2,084,336
+0.9%
0.01%0.0%
Q3 2021$252,659,000
+10.0%
2,065,391
+2.5%
0.01%0.0%
Q2 2021$229,775,000
+0.1%
2,015,750
+5.6%
0.01%0.0%
Q1 2021$229,543,000
+85.4%
1,909,203
+56.7%
0.01%
+50.0%
Q4 2020$123,798,000
+34.2%
1,218,601
+2.2%
0.00%
+33.3%
Q3 2020$92,225,000
-24.1%
1,192,754
+9.4%
0.00%
-25.0%
Q2 2020$121,553,000
+235.3%
1,090,552
+116.6%
0.00%
+100.0%
Q1 2020$36,251,000
+11.9%
503,467
+17.1%
0.00%
+100.0%
Q4 2019$32,393,000
+794.6%
429,954
+93.8%
0.00%
Q3 2019$3,621,000
+179.8%
221,880
+243.4%
0.00%
Q2 2019$1,294,00064,6120.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders